STAT3 and central nervous system cancer: SD-36 selectively degraded STAT3 (Figure 2), including mutated STAT3 proteins over other STAT proteins, even though they share a conserved SH2 domain (323) in various leukemia, lymphoma (323) and glioma cell lines (324).